C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
12/1999
12/29/1999	CA2335356A1 Nitrate salts of antihypertensive medicines
12/29/1999	CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors
12/23/1999	WO1999065877A1 Therapeutic biaryl derivatives
12/22/1999	EP0733033B1 Pharmaceutically active substituted aromatic compounds
12/21/1999	US6005117 Imino compounds, process for their preparation and their use as victronectin antagonists
12/21/1999	US6005083 Substituted metal chelating compounds for imaging and therapy
12/21/1999	US6004988 Carboxylic acid derivatives, their preparation and their use
12/16/1999	WO1999064156A1 Long-lived homogenous amide containing macrocyclic compounds
12/16/1999	WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	WO1999064050A1 Novel potassium channel drugs and their uses
12/16/1999	WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999	WO1999064038A1 Novel analgesic agents
12/16/1999	WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	WO1999063999A1 H1-histamine receptor antagonists
12/16/1999	WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999	WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999	CA2321273A1 Novel analgesic agents
12/16/1999	CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999	CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	CA2319651A1 H1-histamine receptor antagonists
12/16/1999	CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999	CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999	CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999	CA2318745A1 Novel potassium channel drugs and their uses
12/16/1999	CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999	CA2318055A1 .beta.2-adrenergic receptor agonists
12/09/1999	WO1999062506A1 Use of compounds for the elevation of pyruvate dehydrogenase activity
12/08/1999	EP0961617A1 Leukotriene antagonists for cerebral focal stroke
12/08/1999	EP0678086B1 Compounds having selectivity for retinoid x receptors
12/08/1999	EP0594837B2 Radiolabelled compound formulations
12/07/1999	US5998424 Anticoagulants
12/02/1999	WO1999061410A1 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
12/02/1999	CA2331056A1 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
12/01/1999	EP0960879A2 Improved process for the preparation of 5-aminotetrazole
12/01/1999	EP0960108A1 Matrix metalloproteinase inhibitors
11/1999
11/30/1999	US5994536 Process for mono- and 1,7-bis-N-β-hydroxyalkylation of cyclene; N-β-hydroxyalkyl-1,4,7,10-tetraazacyclododecane-lithium-salt complexes and the use of the complexes for the production of gadobutrol and analogs
11/30/1999	US5994398 Alzheimer's disease
11/25/1999	WO1999059973A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999	WO1999059957A1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
11/25/1999	CA2332279A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/23/1999	US5990166 Compounds and compositions for delivering active agents
11/18/1999	WO1999058634A1 Metal ligand containing bleaching compositions
11/18/1999	DE4414091C2 Verfahren zur Herstellung von schutzgruppentragenden Azakronenethern Process for the preparation of protective-group-containing aza crown ethers
11/11/1999	WO1999056765A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
11/11/1999	CA2327507A1 Succinamide inhibitors of interleukin-1.beta. converting enzyme
11/10/1999	EP0955044A2 Method of inhibiting bacterial or fungal growth using a complexing agent
11/09/1999	US5981580 Fatty acid analogs and prodrugs
11/09/1999	US5981438 1-phenyl-5-anilinotetrazoles
11/09/1999	US5980864 1,4,7,10-tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them
11/04/1999	WO1999055681A1 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same
11/04/1999	WO1999055661A1 Aminomethyl-benzoic ester derivatives as tryptase inhibitors
11/04/1999	WO1999031074A3 ((cyclo)alkyl substituted)-.gamma.-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders
11/02/1999	US5977376 Herbicidal 2-benzoylcyclohexane-1,3-diones and related compounds
11/02/1999	US5977372 Chloro or bromo[2-[2-(tert-butyl)-2H-tetrazol-5-yl]phenyl]zinc intermediates
11/02/1999	US5977353 1,4,7,10-tetraazabicyclo[8.2.2]tetradecan-2-one, a process for the preparation thereof and the use thereof for the preparation of tetraazamacrocycles
11/02/1999	US5977154 Obesity, diabetes
10/1999
10/27/1999	CN1045958C Tetrazolinones compound and its preparation weed killing composition containing the same and its use as herbicides
10/26/1999	US5972978 Modulators of molecules with phosphotyrosine recognition units
10/26/1999	US5972307 Administering to human or animal body an effective amount of a diagnostic agent comprises a metal chelate of a compound having two macrocyclic chelant groups linked by a bridge containing ester or amide bond
10/21/1999	WO1999052874A1 Difluoroalkene derivatives, process for producing the same, and agricultural or horticultural pest control agent
10/21/1999	DE19816922A1 Synthetic cyclic peptides used as models for conformational analysis and as potential drugs
10/20/1999	EP0950656A1 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
10/20/1999	EP0778821B1 Ortho-substituted aromatic ether compounds and their use in pharmaceutical compositions for pain relief
10/20/1999	CN1232462A Muscarinic antagonists
10/20/1999	CN1232028A Derivatives of phenoxy acetic acid and of phenoxymethyl tetrazole having antitumor activity
10/20/1999	CN1045772C Polyazacycloalkanes as dichelants
10/19/1999	US5969134 Cardiovascular disorders, vasoconstriction, hypotensive agents and release of endothelins
10/19/1999	US5968963 PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption
10/13/1999	EP0763523B1 Naphthalene derivative
10/13/1999	CN1231665A Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/12/1999	US5965763 Biphenyl compounds
10/12/1999	US5965741 Ortho-substituted aromatic ether compounds and their use in pharmaceutical compositions for pain relief
10/12/1999	US5965592 Acyl compounds
10/12/1999	US5965496 Perfluoropolyether polymers and compounds having free radical, nitrogen-containing end groups to provide improved adhesion and durability to the surface of the magnetic recording medium
10/07/1999	WO1999050241A1 C11 oxymyl and hydroxylamino prostaglandins useful as medicaments
10/07/1999	WO1999050229A1 Fatty acid analogs and prodrugs
10/06/1999	EP0947511A1 Derivatives of phenoxy acetic acid and of phenoxymethyl tetrazole having antitumor activity
10/06/1999	EP0947494A1 Derivatives of phenoxy acetic acid and phenoxymethyltetrazole having antitumor activity
10/06/1999	EP0946526A1 Macrocyclic metal complex carboxylic acids, use and method for the production thereof
10/06/1999	EP0946525A1 Method for producing metal complex carboxylic acid amides
10/06/1999	EP0946508A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS

1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 97